11/13/2024 4:06 PM | Appajosyula Sireesh (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2024 4:22 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024 3:15 PM | MILBY RANDY (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/09/2024 8:58 AM | Appajosyula Sireesh (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4/A | |
10/08/2024 3:10 PM | Appajosyula Sireesh (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 9:00 AM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 8:06 AM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
08/12/2024 4:17 PM | MILBY RANDY (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 4:17 PM | Bui Lynne A. (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 4:18 PM | Mazur Leonard L (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 4:18 PM | Appajosyula Sireesh (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 4:18 PM | Anderson Kelly (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 2:09 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024 3:13 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 424B3 | |
07/21/2024 11:15 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form EFFECT | |
07/15/2024 3:43 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/28/2024 4:25 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
06/20/2024 3:15 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2024 3:14 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/07/2024 4:21 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 424B5 | |
06/07/2024 4:23 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2024 3:15 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 7:30 AM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024 10:12 AM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form DEFA14A | |
03/22/2024 10:08 AM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form ARS | |
03/21/2024 4:25 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form DEF 14A | |
03/21/2024 4:27 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form DEFA14A | |
03/11/2024 3:30 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form PRE 14A | |
03/11/2024 3:15 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/23/2024 7:30 AM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
12/18/2023 9:04 AM | MILBY RANDY (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:15 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 5:15 AM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K/A | |
12/08/2023 6:31 AM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 7:13 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2023 3:15 PM | MILBY RANDY (Reporting) Hillstream BioPharma (Issuer) Tharimmune, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 11:15 PM | Hillstream BioPharma (Filer) Tharimmune, Inc. (Filer)
| Form EFFECT | |